nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—SBK1—eye—autistic disorder	0.0129	0.0352	CbGeAlD
Gefitinib—ERBB3—mouth—autistic disorder	0.0108	0.0295	CbGeAlD
Gefitinib—MAP2K5—hindbrain—autistic disorder	0.00849	0.0232	CbGeAlD
Gefitinib—SBK1—head—autistic disorder	0.00731	0.02	CbGeAlD
Gefitinib—CSNK1E—forebrain—autistic disorder	0.00705	0.0193	CbGeAlD
Gefitinib—ERBB3—forebrain—autistic disorder	0.0068	0.0186	CbGeAlD
Gefitinib—EGFR—telencephalon—autistic disorder	0.00674	0.0184	CbGeAlD
Gefitinib—MKNK2—eye—autistic disorder	0.00652	0.0178	CbGeAlD
Gefitinib—SBK1—cerebellum—autistic disorder	0.00652	0.0178	CbGeAlD
Gefitinib—CSNK1E—telencephalon—autistic disorder	0.00648	0.0177	CbGeAlD
Gefitinib—MKNK1—eye—autistic disorder	0.00644	0.0176	CbGeAlD
Gefitinib—ERBB3—telencephalon—autistic disorder	0.00625	0.0171	CbGeAlD
Gefitinib—MKNK2—telencephalon—autistic disorder	0.00595	0.0163	CbGeAlD
Gefitinib—IRAK1—telencephalon—autistic disorder	0.00595	0.0163	CbGeAlD
Gefitinib—MKNK1—telencephalon—autistic disorder	0.00587	0.0161	CbGeAlD
Gefitinib—EPHA6—head—autistic disorder	0.00571	0.0156	CbGeAlD
Gefitinib—EPHA6—nervous system—autistic disorder	0.00541	0.0148	CbGeAlD
Gefitinib—SBK1—brain—autistic disorder	0.0053	0.0145	CbGeAlD
Gefitinib—HIPK4—brain—autistic disorder	0.00523	0.0143	CbGeAlD
Gefitinib—EPHA6—central nervous system—autistic disorder	0.00521	0.0143	CbGeAlD
Gefitinib—MAP3K19—head—autistic disorder	0.00519	0.0142	CbGeAlD
Gefitinib—CSNK1E—digestive system—autistic disorder	0.00495	0.0135	CbGeAlD
Gefitinib—MAP3K19—nervous system—autistic disorder	0.00492	0.0135	CbGeAlD
Gefitinib—MAP2K5—brainstem—autistic disorder	0.00487	0.0133	CbGeAlD
Gefitinib—ERBB3—digestive system—autistic disorder	0.00477	0.0131	CbGeAlD
Gefitinib—MAP3K19—central nervous system—autistic disorder	0.00474	0.013	CbGeAlD
Gefitinib—CHEK2—brain—autistic disorder	0.00461	0.0126	CbGeAlD
Gefitinib—MKNK2—digestive system—autistic disorder	0.00454	0.0124	CbGeAlD
Gefitinib—MKNK1—digestive system—autistic disorder	0.00448	0.0123	CbGeAlD
Gefitinib—MAP2K5—telencephalon—autistic disorder	0.00432	0.0118	CbGeAlD
Gefitinib—EPHA6—brain—autistic disorder	0.00414	0.0113	CbGeAlD
Gefitinib—CSNK1E—head—autistic disorder	0.00404	0.011	CbGeAlD
Gefitinib—IRAK4—head—autistic disorder	0.00397	0.0109	CbGeAlD
Gefitinib—Cisapride—HTR3A—autistic disorder	0.00396	0.169	CrCbGaD
Gefitinib—ERBB3—head—autistic disorder	0.00389	0.0107	CbGeAlD
Gefitinib—CSNK1E—nervous system—autistic disorder	0.00383	0.0105	CbGeAlD
Gefitinib—IRAK4—nervous system—autistic disorder	0.00377	0.0103	CbGeAlD
Gefitinib—MAP3K19—brain—autistic disorder	0.00376	0.0103	CbGeAlD
Gefitinib—EGFR—cerebellum—autistic disorder	0.00374	0.0102	CbGeAlD
Gefitinib—MKNK2—head—autistic disorder	0.0037	0.0101	CbGeAlD
Gefitinib—ERBB3—nervous system—autistic disorder	0.00369	0.0101	CbGeAlD
Gefitinib—STK10—digestive system—autistic disorder	0.00369	0.0101	CbGeAlD
Gefitinib—CSNK1E—central nervous system—autistic disorder	0.00368	0.0101	CbGeAlD
Gefitinib—MKNK1—head—autistic disorder	0.00366	0.01	CbGeAlD
Gefitinib—IRAK4—central nervous system—autistic disorder	0.00363	0.00992	CbGeAlD
Gefitinib—Iloperidone—HTR1D—autistic disorder	0.00361	0.154	CrCbGaD
Gefitinib—CSNK1E—cerebellum—autistic disorder	0.0036	0.00985	CbGeAlD
Gefitinib—ERBB3—central nervous system—autistic disorder	0.00355	0.00972	CbGeAlD
Gefitinib—IRAK4—cerebellum—autistic disorder	0.00354	0.0097	CbGeAlD
Gefitinib—MKNK2—nervous system—autistic disorder	0.00351	0.0096	CbGeAlD
Gefitinib—ERBB3—cerebellum—autistic disorder	0.00347	0.0095	CbGeAlD
Gefitinib—MKNK1—nervous system—autistic disorder	0.00347	0.00948	CbGeAlD
Gefitinib—CYP1A1—mouth—autistic disorder	0.00344	0.00941	CbGeAlD
Gefitinib—MKNK2—central nervous system—autistic disorder	0.00338	0.00925	CbGeAlD
Gefitinib—MKNK1—central nervous system—autistic disorder	0.00334	0.00913	CbGeAlD
Gefitinib—MKNK2—cerebellum—autistic disorder	0.0033	0.00904	CbGeAlD
Gefitinib—IRAK1—cerebellum—autistic disorder	0.0033	0.00904	CbGeAlD
Gefitinib—MKNK1—cerebellum—autistic disorder	0.00326	0.00892	CbGeAlD
Gefitinib—Minaprine—MAOA—autistic disorder	0.00308	0.132	CrCbGaD
Gefitinib—EGFR—brain—autistic disorder	0.00304	0.00832	CbGeAlD
Gefitinib—STK10—head—autistic disorder	0.00301	0.00824	CbGeAlD
Gefitinib—CSNK1E—brain—autistic disorder	0.00292	0.008	CbGeAlD
Gefitinib—IRAK4—brain—autistic disorder	0.00288	0.00788	CbGeAlD
Gefitinib—STK10—nervous system—autistic disorder	0.00285	0.00781	CbGeAlD
Gefitinib—CYP2D6—hindbrain—autistic disorder	0.00283	0.00774	CbGeAlD
Gefitinib—ERBB3—brain—autistic disorder	0.00282	0.00772	CbGeAlD
Gefitinib—Minaprine—DRD1—autistic disorder	0.0028	0.12	CrCbGaD
Gefitinib—STK10—central nervous system—autistic disorder	0.00275	0.00752	CbGeAlD
Gefitinib—MAP2K5—head—autistic disorder	0.00269	0.00735	CbGeAlD
Gefitinib—STK10—cerebellum—autistic disorder	0.00269	0.00735	CbGeAlD
Gefitinib—MKNK2—brain—autistic disorder	0.00268	0.00734	CbGeAlD
Gefitinib—IRAK1—brain—autistic disorder	0.00268	0.00734	CbGeAlD
Gefitinib—MKNK1—brain—autistic disorder	0.00265	0.00725	CbGeAlD
Gefitinib—MAP2K5—nervous system—autistic disorder	0.00255	0.00697	CbGeAlD
Gefitinib—MAP2K5—central nervous system—autistic disorder	0.00245	0.00671	CbGeAlD
Gefitinib—MAP2K5—cerebellum—autistic disorder	0.0024	0.00656	CbGeAlD
Gefitinib—STK10—brain—autistic disorder	0.00218	0.00597	CbGeAlD
Gefitinib—ABCG2—telencephalon—autistic disorder	0.0021	0.00575	CbGeAlD
Gefitinib—Iloperidone—DRD3—autistic disorder	0.00208	0.0889	CrCbGaD
Gefitinib—ORM1—nervous system—autistic disorder	0.00207	0.00566	CbGeAlD
Gefitinib—Iloperidone—DRD1—autistic disorder	0.00204	0.0873	CrCbGaD
Gefitinib—ORM1—central nervous system—autistic disorder	0.00199	0.00545	CbGeAlD
Gefitinib—Minaprine—SLC6A4—autistic disorder	0.00198	0.0848	CrCbGaD
Gefitinib—MAP2K5—brain—autistic disorder	0.00195	0.00533	CbGeAlD
Gefitinib—CYP2C19—digestive system—autistic disorder	0.00189	0.00517	CbGeAlD
Gefitinib—CYP2D6—brainstem—autistic disorder	0.00162	0.00444	CbGeAlD
Gefitinib—CYP2D6—forebrain—autistic disorder	0.00157	0.00428	CbGeAlD
Gefitinib—Minaprine—HTR2A—autistic disorder	0.00152	0.0652	CrCbGaD
Gefitinib—CYP1A1—digestive system—autistic disorder	0.00152	0.00416	CbGeAlD
Gefitinib—CYP3A5—digestive system—autistic disorder	0.00149	0.00407	CbGeAlD
Gefitinib—CYP2C9—digestive system—autistic disorder	0.00146	0.00401	CbGeAlD
Gefitinib—CYP2D6—telencephalon—autistic disorder	0.00144	0.00394	CbGeAlD
Gefitinib—ALB—brain—autistic disorder	0.00139	0.00379	CbGeAlD
Gefitinib—CYP1A1—head—autistic disorder	0.00124	0.0034	CbGeAlD
Gefitinib—Cisapride—HTR2A—autistic disorder	0.00121	0.0515	CrCbGaD
Gefitinib—CYP1A1—nervous system—autistic disorder	0.00118	0.00322	CbGeAlD
Gefitinib—ABCG2—cerebellum—autistic disorder	0.00117	0.00319	CbGeAlD
Gefitinib—CYP1A1—central nervous system—autistic disorder	0.00113	0.0031	CbGeAlD
Gefitinib—ABCB1—forebrain—autistic disorder	0.00113	0.00308	CbGeAlD
Gefitinib—CYP3A4—digestive system—autistic disorder	0.00112	0.00306	CbGeAlD
Gefitinib—Iloperidone—HTR2A—autistic disorder	0.00111	0.0476	CrCbGaD
Gefitinib—CYP2D6—digestive system—autistic disorder	0.0011	0.00301	CbGeAlD
Gefitinib—ABCB1—telencephalon—autistic disorder	0.00104	0.00283	CbGeAlD
Gefitinib—ABCG2—brain—autistic disorder	0.000948	0.00259	CbGeAlD
Gefitinib—CYP1A1—brain—autistic disorder	0.0009	0.00246	CbGeAlD
Gefitinib—CYP2D6—head—autistic disorder	0.000897	0.00245	CbGeAlD
Gefitinib—CYP3A4—nervous system—autistic disorder	0.000864	0.00236	CbGeAlD
Gefitinib—CYP2D6—nervous system—autistic disorder	0.00085	0.00233	CbGeAlD
Gefitinib—CYP3A4—central nervous system—autistic disorder	0.000832	0.00228	CbGeAlD
Gefitinib—CYP2D6—central nervous system—autistic disorder	0.000819	0.00224	CbGeAlD
Gefitinib—CYP2D6—cerebellum—autistic disorder	0.0008	0.00219	CbGeAlD
Gefitinib—ABCB1—digestive system—autistic disorder	0.000791	0.00216	CbGeAlD
Gefitinib—CYP2D6—brain—autistic disorder	0.00065	0.00178	CbGeAlD
Gefitinib—ABCB1—head—autistic disorder	0.000645	0.00176	CbGeAlD
Gefitinib—ABCB1—nervous system—autistic disorder	0.000612	0.00167	CbGeAlD
Gefitinib—ABCB1—central nervous system—autistic disorder	0.000589	0.00161	CbGeAlD
Gefitinib—ABCB1—cerebellum—autistic disorder	0.000575	0.00157	CbGeAlD
Gefitinib—ABCB1—brain—autistic disorder	0.000467	0.00128	CbGeAlD
Gefitinib—CYP3A4—Metabolism—SLC25A12—autistic disorder	2.65e-05	4.34e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—DPYD—autistic disorder	2.65e-05	4.33e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—EGF—autistic disorder	2.65e-05	4.33e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—SERPINE1—autistic disorder	2.65e-05	4.33e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—NOS2—autistic disorder	2.64e-05	4.32e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—MAOB—autistic disorder	2.64e-05	4.32e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—POMC—autistic disorder	2.64e-05	4.31e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—TPH2—autistic disorder	2.63e-05	4.3e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—HRAS—autistic disorder	2.6e-05	4.26e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—DPYD—autistic disorder	2.58e-05	4.23e-05	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—IL6—autistic disorder	2.58e-05	4.22e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—GPX1—autistic disorder	2.58e-05	4.22e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—SLC19A1—autistic disorder	2.58e-05	4.22e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—AVP—autistic disorder	2.56e-05	4.2e-05	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—MAPK1—autistic disorder	2.56e-05	4.19e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—APC—autistic disorder	2.56e-05	4.18e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IGF2—autistic disorder	2.55e-05	4.18e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—POMC—autistic disorder	2.55e-05	4.17e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—EGF—autistic disorder	2.53e-05	4.14e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—autistic disorder	2.51e-05	4.11e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—DHFR—autistic disorder	2.49e-05	4.08e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—IL6—autistic disorder	2.49e-05	4.08e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	2.49e-05	4.07e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—TPH2—autistic disorder	2.48e-05	4.05e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—MAPK1—autistic disorder	2.47e-05	4.05e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—CACNA1C—autistic disorder	2.46e-05	4.03e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—TPH2—autistic disorder	2.45e-05	4.02e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IGF1—autistic disorder	2.45e-05	4.01e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—DPYD—autistic disorder	2.44e-05	3.99e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—DPYD—autistic disorder	2.41e-05	3.95e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—PLA2G4A—autistic disorder	2.41e-05	3.95e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—CACNA1C—autistic disorder	2.4e-05	3.93e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—MTHFR—autistic disorder	2.38e-05	3.89e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—autistic disorder	2.37e-05	3.87e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—IL2—autistic disorder	2.35e-05	3.84e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—MEF2C—autistic disorder	2.35e-05	3.84e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—HRAS—autistic disorder	2.35e-05	3.84e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—SERPINE1—autistic disorder	2.33e-05	3.81e-05	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—HRAS—autistic disorder	2.33e-05	3.81e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	2.31e-05	3.78e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ADSL—autistic disorder	2.3e-05	3.76e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—ITGB3—autistic disorder	2.29e-05	3.74e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—MAPK1—autistic disorder	2.27e-05	3.72e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—CYP19A1—autistic disorder	2.27e-05	3.71e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	2.27e-05	3.71e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—CACNA1C—autistic disorder	2.26e-05	3.71e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—IL2—autistic disorder	2.26e-05	3.7e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—XDH—autistic disorder	2.25e-05	3.69e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—IL6—autistic disorder	2.24e-05	3.67e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—CACNA1C—autistic disorder	2.24e-05	3.67e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—DHFR—autistic disorder	2.24e-05	3.66e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—MAPK1—autistic disorder	2.23e-05	3.65e-05	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—IL6—autistic disorder	2.23e-05	3.64e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—SERPINE1—autistic disorder	2.22e-05	3.64e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—APOE—autistic disorder	2.21e-05	3.63e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—BCL2—autistic disorder	2.21e-05	3.62e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—STX1A—autistic disorder	2.21e-05	3.62e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—NPAS2—autistic disorder	2.21e-05	3.62e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—PTEN—autistic disorder	2.21e-05	3.62e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IFNG—autistic disorder	2.19e-05	3.59e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—DHFR—autistic disorder	2.19e-05	3.58e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—autistic disorder	2.16e-05	3.53e-05	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—HRAS—autistic disorder	2.15e-05	3.52e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—CYP19A1—autistic disorder	2.14e-05	3.51e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—IL2—autistic disorder	2.14e-05	3.5e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—TCN2—autistic disorder	2.14e-05	3.49e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—HTR2A—autistic disorder	2.13e-05	3.49e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—IL2—autistic disorder	2.13e-05	3.49e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—PTEN—autistic disorder	2.13e-05	3.49e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—COMT—autistic disorder	2.11e-05	3.45e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	2.1e-05	3.44e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—GSTP1—autistic disorder	2.1e-05	3.44e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—MAOA—autistic disorder	2.09e-05	3.43e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—DHFR—autistic disorder	2.06e-05	3.37e-05	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL6—autistic disorder	2.06e-05	3.37e-05	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—HRAS—autistic disorder	2.05e-05	3.36e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—CAT—autistic disorder	2.04e-05	3.34e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—DHFR—autistic disorder	2.04e-05	3.34e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ADA—autistic disorder	2.04e-05	3.33e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TSC2—autistic disorder	2.03e-05	3.32e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	2.01e-05	3.29e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PIK3CG—autistic disorder	2e-05	3.27e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—COMT—autistic disorder	1.99e-05	3.26e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—HRAS—autistic disorder	1.98e-05	3.25e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—APOE—autistic disorder	1.98e-05	3.25e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—LEP—autistic disorder	1.98e-05	3.25e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—GSTP1—autistic disorder	1.98e-05	3.25e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—MAOA—autistic disorder	1.98e-05	3.24e-05	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—HRAS—autistic disorder	1.97e-05	3.23e-05	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—IL6—autistic disorder	1.97e-05	3.22e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—CYP19A1—autistic disorder	1.95e-05	3.2e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL2—autistic disorder	1.95e-05	3.19e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—PTGS2—autistic disorder	1.94e-05	3.18e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—CAT—autistic disorder	1.93e-05	3.16e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PLA2G4A—autistic disorder	1.93e-05	3.16e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—GSTM1—autistic disorder	1.93e-05	3.16e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—POMC—autistic disorder	1.9e-05	3.11e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—IL6—autistic disorder	1.9e-05	3.11e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	1.89e-05	3.09e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IL2—autistic disorder	1.88e-05	3.08e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—PRKCB—autistic disorder	1.87e-05	3.06e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—RORA—autistic disorder	1.86e-05	3.04e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—GPX1—autistic disorder	1.85e-05	3.02e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.83e-05	3e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—PTEN—autistic disorder	1.83e-05	3e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—HRAS—autistic disorder	1.82e-05	2.99e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—GSTM1—autistic disorder	1.82e-05	2.98e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PLA2G4A—autistic disorder	1.82e-05	2.98e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—COMT—autistic disorder	1.82e-05	2.97e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—GSTP1—autistic disorder	1.81e-05	2.96e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—MAOA—autistic disorder	1.8e-05	2.95e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—MAPK1—autistic disorder	1.8e-05	2.94e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—APC—autistic disorder	1.79e-05	2.93e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—PIK3CG—autistic disorder	1.79e-05	2.93e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—HRAS—autistic disorder	1.79e-05	2.93e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—PTEN—autistic disorder	1.77e-05	2.9e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—EGF—autistic disorder	1.77e-05	2.9e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—CAT—autistic disorder	1.76e-05	2.88e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—CYP19A1—autistic disorder	1.75e-05	2.87e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—IL6—autistic disorder	1.75e-05	2.86e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—GPX1—autistic disorder	1.75e-05	2.86e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—MAOB—autistic disorder	1.74e-05	2.85e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—MAPK1—autistic disorder	1.73e-05	2.83e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	1.72e-05	2.82e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL6—autistic disorder	1.71e-05	2.8e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—CYP19A1—autistic disorder	1.71e-05	2.8e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—MTHFR—autistic disorder	1.7e-05	2.79e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—POMC—autistic disorder	1.7e-05	2.79e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—PTEN—autistic disorder	1.69e-05	2.77e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PLA2G4A—autistic disorder	1.66e-05	2.72e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—GSTM1—autistic disorder	1.66e-05	2.72e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.65e-05	2.69e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IGF1—autistic disorder	1.64e-05	2.68e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—MAPK1—autistic disorder	1.64e-05	2.68e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—MAPK1—autistic disorder	1.63e-05	2.67e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—COMT—autistic disorder	1.63e-05	2.67e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—GSTP1—autistic disorder	1.62e-05	2.66e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—MAOA—autistic disorder	1.62e-05	2.65e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—TPH2—autistic disorder	1.62e-05	2.65e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—CYP19A1—autistic disorder	1.61e-05	2.64e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—MTHFR—autistic disorder	1.61e-05	2.64e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—CYP19A1—autistic disorder	1.6e-05	2.62e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—DPYD—autistic disorder	1.59e-05	2.61e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—COMT—autistic disorder	1.59e-05	2.6e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—GPX1—autistic disorder	1.59e-05	2.6e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—APOE—autistic disorder	1.59e-05	2.6e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—GSTP1—autistic disorder	1.58e-05	2.59e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—MAOA—autistic disorder	1.58e-05	2.59e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—CAT—autistic disorder	1.58e-05	2.58e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—SERPINE1—autistic disorder	1.56e-05	2.55e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—CAT—autistic disorder	1.54e-05	2.52e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PTGS2—autistic disorder	1.52e-05	2.48e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.5e-05	2.46e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—COMT—autistic disorder	1.5e-05	2.45e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—APOE—autistic disorder	1.5e-05	2.45e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—GSTP1—autistic disorder	1.49e-05	2.44e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PLA2G4A—autistic disorder	1.49e-05	2.44e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—GSTM1—autistic disorder	1.49e-05	2.44e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—MAPK1—autistic disorder	1.49e-05	2.44e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—MAOA—autistic disorder	1.49e-05	2.44e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—COMT—autistic disorder	1.49e-05	2.43e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CACNA1C—autistic disorder	1.48e-05	2.42e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—GSTP1—autistic disorder	1.48e-05	2.42e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—MAOA—autistic disorder	1.48e-05	2.42e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—MTHFR—autistic disorder	1.47e-05	2.4e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PLA2G4A—autistic disorder	1.46e-05	2.38e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—GSTM1—autistic disorder	1.46e-05	2.38e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—CAT—autistic disorder	1.45e-05	2.38e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—HRAS—autistic disorder	1.44e-05	2.36e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—MAPK1—autistic disorder	1.44e-05	2.36e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—CAT—autistic disorder	1.44e-05	2.36e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PIK3CG—autistic disorder	1.43e-05	2.34e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—GPX1—autistic disorder	1.43e-05	2.34e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—GPX1—autistic disorder	1.39e-05	2.28e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—HRAS—autistic disorder	1.39e-05	2.27e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—IL6—autistic disorder	1.38e-05	2.26e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—MAPK1—autistic disorder	1.38e-05	2.25e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PLA2G4A—autistic disorder	1.37e-05	2.24e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—GSTM1—autistic disorder	1.37e-05	2.24e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—APOE—autistic disorder	1.37e-05	2.24e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—POMC—autistic disorder	1.36e-05	2.23e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PLA2G4A—autistic disorder	1.36e-05	2.23e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—GSTM1—autistic disorder	1.36e-05	2.23e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PIK3CG—autistic disorder	1.35e-05	2.21e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—DHFR—autistic disorder	1.35e-05	2.2e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—IL6—autistic disorder	1.33e-05	2.18e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PTEN—autistic disorder	1.32e-05	2.17e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—MTHFR—autistic disorder	1.32e-05	2.16e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—HRAS—autistic disorder	1.31e-05	2.15e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—GPX1—autistic disorder	1.31e-05	2.15e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—HRAS—autistic disorder	1.31e-05	2.14e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—GPX1—autistic disorder	1.3e-05	2.13e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—POMC—autistic disorder	1.29e-05	2.11e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—MTHFR—autistic disorder	1.29e-05	2.11e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IL2—autistic disorder	1.26e-05	2.06e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—IL6—autistic disorder	1.25e-05	2.05e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PIK3CG—autistic disorder	1.23e-05	2.02e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—APOE—autistic disorder	1.23e-05	2.01e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—MTHFR—autistic disorder	1.21e-05	1.98e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—MTHFR—autistic disorder	1.2e-05	1.97e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—APOE—autistic disorder	1.2e-05	1.96e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—HRAS—autistic disorder	1.2e-05	1.96e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—PTEN—autistic disorder	1.19e-05	1.94e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—POMC—autistic disorder	1.17e-05	1.92e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—HRAS—autistic disorder	1.16e-05	1.89e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL6—autistic disorder	1.15e-05	1.87e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—APOE—autistic disorder	1.13e-05	1.85e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—APOE—autistic disorder	1.12e-05	1.83e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IL6—autistic disorder	1.11e-05	1.81e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PIK3CG—autistic disorder	1.11e-05	1.81e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—HRAS—autistic disorder	1.1e-05	1.81e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PTGS2—autistic disorder	1.09e-05	1.78e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PIK3CG—autistic disorder	1.08e-05	1.77e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—IL6—autistic disorder	1.06e-05	1.73e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CYP19A1—autistic disorder	1.05e-05	1.73e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—POMC—autistic disorder	1.05e-05	1.73e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—POMC—autistic disorder	1.03e-05	1.68e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PTGS2—autistic disorder	1.03e-05	1.68e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PIK3CG—autistic disorder	1.02e-05	1.67e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PIK3CG—autistic disorder	1.01e-05	1.65e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—COMT—autistic disorder	9.8e-06	1.6e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GSTP1—autistic disorder	9.76e-06	1.6e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—MAOA—autistic disorder	9.74e-06	1.59e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—POMC—autistic disorder	9.69e-06	1.59e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—MAPK1—autistic disorder	9.64e-06	1.58e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—POMC—autistic disorder	9.61e-06	1.57e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CAT—autistic disorder	9.5e-06	1.55e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PTEN—autistic disorder	9.48e-06	1.55e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PTGS2—autistic disorder	9.36e-06	1.53e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PLA2G4A—autistic disorder	8.97e-06	1.47e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GSTM1—autistic disorder	8.97e-06	1.47e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PTEN—autistic disorder	8.96e-06	1.47e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GPX1—autistic disorder	8.59e-06	1.41e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PTGS2—autistic disorder	8.41e-06	1.38e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PTGS2—autistic disorder	8.21e-06	1.34e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PTEN—autistic disorder	8.17e-06	1.34e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—MTHFR—autistic disorder	7.92e-06	1.3e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—HRAS—autistic disorder	7.74e-06	1.27e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PTGS2—autistic disorder	7.73e-06	1.27e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PTGS2—autistic disorder	7.67e-06	1.25e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IL6—autistic disorder	7.41e-06	1.21e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—APOE—autistic disorder	7.38e-06	1.21e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PTEN—autistic disorder	7.33e-06	1.2e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PTEN—autistic disorder	7.16e-06	1.17e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PTEN—autistic disorder	6.74e-06	1.1e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PTEN—autistic disorder	6.68e-06	1.09e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PIK3CG—autistic disorder	6.66e-06	1.09e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—POMC—autistic disorder	6.34e-06	1.04e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PTGS2—autistic disorder	5.06e-06	8.27e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PTEN—autistic disorder	4.41e-06	7.22e-06	CbGpPWpGaD
